Search results
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript February 22, 2024...
Is BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Recent Stock Performance Influenced By Its...
Simply Wall St. via Yahoo Finance· 4 months agoBioMarin Pharmaceutical (NASDAQ:BMRN) has had a great run on the share market with its stock up by a...
BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock Has Shown Weakness Lately But Financial Prospects...
Simply Wall St. via Yahoo Finance· 11 months agoIt is hard to get excited after looking at BioMarin Pharmaceutical's (NASDAQ:BMRN) recent...
Insider Sell: EVP, Chief Legal Officer George Davis Sells 13,764 Shares of Biomarin ...
GuruFocus.com via Yahoo Finance· 6 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and...
Is BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Trading At A 49% Discount?
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights The projected fair value for BioMarin Pharmaceutical is US$193 based on 2 Stage Free...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Looks Inexpensive But Perhaps Not Attractive Enough
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 8.8x BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) may be...
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the...
Simply Wall St. via Yahoo Finance· 2 weeks agoIt's easy to match the overall market return by buying an index fund. Active investors aim to buy...
PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
GuruFocus.com via Yahoo Finance· 4 months agoOn the last day of 2023, PRIMECAP Management (Trades, Portfolio) made a notable addition to its...
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
BioMarin Pharmaceutical's (NASDAQ:BMRN) investors will be pleased with their 13% return over the...
Simply Wall St. via Yahoo Finance· 7 months agoInvestors can buy low cost index fund if they want to receive the average market return. But in any...